Authors: COLLINS R PETO R FLATHER M PARISH S SLEIGHT P CONWAY M PIPILIS A BAIGENT C BARNETT D BOISSEL JP BUDAJ A CAIRNS J CEREMUZYNSKI L COHEN AF DEBACKER G DIAZ R DIENSTL F DOVE P FRANZOSI MG GENONI M HALON DA HEIKKILA J HENNEKENS C HORGAN J HUNT D KALA R KARATZAS N KEECH A KELTAI M KJEKSHUS J KORNITZER M KOSTER R LANDLESS P LECHLEITNER P LEIZOROVICZ A LEWIS BS LUNDKVIST L MACMAHON S MAGGIONI A MALACRIDA R MEYER T MOCCETTI T OCALLAGHAN D PAOLASSO E PIEGAS LS REIKVAM A RIDKER P RYAN T SCHRODER R SEABRAGOMES R SOUSA JEMR TOGNONI G TURPIE A VALENTIN V VARIGOS J WHITE H WILHELMSEN L WOODS K YUSUF S PIOMBO A GUZMAN LA MONTENEGRO DC IRUSTA G SCHNEIDER RA CUNEO C CHAMORRO BH ESPINOSA GE MORENO M RIOS MM DOLL R FOX K JULIAN D MEIER P SANDOYA E PEREZ JE

Citation: R. Collins et al., ISIS-4 - A RANDOMIZED FACTORIAL TRIAL ASSESSING EARLY ORAL CAPTOPRIL,ORAL MONONITRATE, AND INTRAVENOUS MAGNESIUM-SULFATE IN 58,050 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION, Lancet, 345(8951), 1995, pp. 669-685